TrialBreast cancer research and treatment2011

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.

Claudine Isaacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.